TLCR Related Analyst Ratings
-
Barclays Initiates Coverage on Talecris Biotherapeutics (TLCR) with an Equalweight
-
Several Brokerage Firms Initiate Coverage on Talecris Biotherapeutics (TLCR)
-
Goldman Sachs Starts Talecris Biotherapeutics (TLCR) at Neutral
-
Wells Fargo Initiates Coverage on Talecris Biotherapeutics (TLCR) with an Outpeform
Back to TLCR Stock Lookup
